Bosutinib structure, CAS 380843-75-4

Bosutinib

CAS Number380843-75-4

SynonymsBosutinib(SKI 606); SKI 606; SKI-606; Bosutinib; Bosutinib (SKI-606); T66 BNJ DCN EMR BG DG EO1& HO1 IO3- AT6N DNTJ D1

Molecular FormulaC26H29O3N5Cl2

Molecular Weight530.45

Purity98.00%

Density1.4±0.1 g/cm3

Boiling Point649.7±55.0 °C at 760 mmHg

Melting Point116-120ºC

Flash Point

Appearance

EINECS

MSDSChineseEnglish

Symboltransportation

Signal WordWarning

Cat. No.: 2A-9056968 Purity: 98.00%
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 380843-75-4 ] Purity: 98.00% SDS Specification MoL

Chemical & Physical Properties
CAS Number380843-75-4
Catalog No.2A-9056968
Chinese Name伯舒替尼
SynonymsBosutinib(SKI 606); SKI 606; SKI-606; Bosutinib; Bosutinib (SKI-606); T66 BNJ DCN EMR BG DG EO1& HO1 IO3- AT6N DNTJ D1
Molecular FormulaC26H29O3N5Cl2
Molecular Weight530.45
Purity98.00
Density1.4±0.1 g/cm3
Boiling Point649.7±55.0 °C at 760 mmHg
Melting Point116-120ºC
Storage Conditionroom temp
ApplicationBosutinib is a dual inhibitor of Src/Abl with IC50 of 1.2 nM and 1 nM respectively.
MDL NumberMFCD07367846
SMILESCOc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl
InChIInChI=1S/C26H29Cl2N5O3/c1-32-6-8-33(9-7-32)5-4-10-36-25-13-21-18(11-24(25)35-3)26(17(15-29)16-30-21)31-22-14-23(34-2)20(28)12-19(22)27/h11-14,16H,4-10H2,1-3H3,(H,30,31)
InChI KeyUBPYILGKFZZVDX-UHFFFAOYSA-N
Hazard Symbolstransportation
MSDSmsds/56968_1_380843_75_4.pdf
BioactivityBosutinib is a dual Src/Abl inhibitor with IC50s of 1.2 nM and 1 nM, respectively. Related Catalog Signaling Pathways >> Protein Tyrosine Kinase/RTK >> Bcr-Abl Signaling Pathways >> Protein Tyrosine Kinase/RTK >> Src Research Areas >> Cancer References [1]. Boschelli DH, et al. Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity. J Med Chem, 2001, 44(23), 3965-3977. [2]. Golas JM, et al. SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice. Cancer Res, 2003, 63(2), 375-381. [3]. Vultur A, et al. SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells. Mol Cancer Ther, 2008, 7(5), 1185-1194. [4]. Golas JM, et al. SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models. Cancer Res, 2005, 65(12), 5358-5364. Chemical & Physical Properties Density 1.4±0.1 g/cm3 Boiling Point 649.7±55.0 °C at 760 mmHg Melting Point 116-120ºC Molecular Formula C26H29Cl2N5O3 Molecular Weight 530.446 Flash Point 346.7±31.5 °C Exact Mass 529.164734 PSA 82.88000 LogP 5.48 Vapour Pressure 0.0±1.9 mmHg at 25°C Index of Refraction 1.652 InChIKey UBPYILGKFZZVDX-UHFFFAOYSA-N SMILES COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl Storage condition room temp
Use ofBosutinib is a dual Src/Abl inhibitor with IC50s of 1.2 nM and 1 nM, respectively. Properties Articles19 Name bosutinib Synonym More Synonyms Bosutinib (SKI-606) Biological Activity Description Bosutinib is a dual Src/Abl inhibitor with IC50s of 1.2 nM and 1 nM, respectively. Related Catalog Signaling Pathways >> Protein Tyrosine Kinase/RTK >> Bcr-Abl Signaling Pathways >> Protein Tyrosine Kinase/RTK >> Src Research Areas >> Cancer References [1]. Boschelli DH, et al. Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity. J Med Chem, 2001, 44(23), 3965-3977. [2]. Golas JM, et al. SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice. Cancer Res, 2003, 63(2), 375-381. [3]. Vultur A, et al. SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells. Mol Cancer Ther, 2008, 7(5), 1185-1194. [4]. Golas JM, et al. SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models. Cancer Res, 2005, 65(12), 5358-5364. Chemical & Physical Properties Exact Mass 529.164734 PSA 82.88000 Index of Refraction 1.652 InChIKey UBPYILGKFZZVDX-UHFFFAOYSA-N Storage condition room temp
Transport InfoProduct name: Purity: 99.0%
MSDS Transport InfoModule 14. Shipping information 14.1 UN dangerous goods number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 Names specified by the United Nations (UN) European Land Transport Dangerous Regulations: Non-dangerous goods IMDG Code: Non-dangerous goods International air transport dangerous goods regulations: non-dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Dangerous Regulations: No International Maritime Transport Dangerous Regulations Maritime Pollutants: No International Air Transport Risk Regulations: No 14.6 Special reminder to users No data available
Related Products in Specialty Chemicals
Piperidin-4-ylmethyl-pyridin-2-yl-amine hydrochloride380396-49-62A-9056956
N-Cyclopropyl-3-nitropyridin-4-amine380605-28-72A-9056963
Talizumab380610-22-02A-9056964
Pertuzumab380610-27-52A-0202034
(5-Aminobenzo[d]isoxazol-3-yl)carbamic acid tert-butyl ester380629-73-22A-9056967
Methyl 2-amino-5-(3-chloropropoxy)-4-methoxybenzoate380844-26-82A-9056969
Valtorcitabine380886-95-32A-9056970
Pyroxamide382180-17-82A-9056973
2-(3-Chlorophenyl)hexahydro-1H-azepine383129-21-32A-9056979
5-(3-Bromophenyl)-4H-1,2,4-triazol-3-amine383130-99-22A-9056980
Browse all Specialty Chemicals products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA